HEPATO-RENAL SYNDROME IN CIRRHOSIS OF THE LIVER. CLINICAL CASE.
Hepato-renal syndrome is one of the formidable complications of liver cirrhosis, which can be fatal. The described clinical case demonstrates a case of liver cirrhosis, which was aggravated by renal failure and hepatic coma due to the development of hepato-renal syndrome. This article shows the severity of the disease, the dynamics of increasing symptoms, and the course of the clinical picture.
In recent years, the prevalence of liver cirrhosis of different etiologies is increasing. The data given in the article will be useful for general practitioners, gastroenterologists and nephrologists.
Aizhan Т. Shakhanova1, http://orcid.org/0000-0001-8214-8575
Zauresh K. Zhumadilova1, https://orcid.org/0000-0001-6211-6154
Alida Sh. Kaskabaeva1, http://orcid.org/0000-0002-5184-214X
Tungyshkhan E. Shakhanov1, http://orcid.org/0000-0002-8698-7541
Gulzhakan K. Kapanova1, http://orcid.org/0000-0001-6574-6581
Ainur S. Botabaeva1, http://orcid.org/0009-0008-9228-7788
Dana K. Kozhakhmetova1, http://orcid.org/0000-0002-8367-1461
Karlygysh Sh. Zhylkybayeva2,
Daulet K. Muzdubaev1, https://orcid.org/0000-0001-8848-4860
1 NJSC «Semey medical university», Semey, Republic of Kazakhstan;
2 University Hospital of NJSC «Semey Medical University», Semey, Republic of Kazakhstan.
1. Acevedo J.G., Cramp M.E. Hepatorenal syndrome: Update on diagnosis and therapy // World J. Hepatol. 2017. Vol. 9, № 6. P. 293–299.
2. Alessandria C. et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation // Hepatology. 2005. Vol. 41, № 6. P. 1282–1289.
3. Angeli P. et al. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document // J. Hepatol. European Association for the Study of the Liver, 2019. Vol. 71, № 4. P. 811–822.
4. Angeli P. et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites // Gut. 2015. Vol. 64, № 4. P. 531–537.
5. Arroyo V. et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club // Hepatology. 1996. Vol. 23, № 1. P. 164–176.
6. Bera C., Wong F. Management of hepatorenal syndrome in liver cirrhosis: a recent update // Therap. Adv. Gastroenterol. 2022. Vol. 15, № 14. P. 17562848221102680.
7. Bernardi M. et al. Hepatorenal disorders: role of the renin-angiotensin-aldosterone system // Semin. Liver Dis. 1994. Vol. 14, № 1. P. 23–34.
8. DellaVolpe J., Al-Khafaji A. Acute Kidney Injury Before and After Liver Transplant // J. Intensive Care Med. 2019. Vol. 34, № 9. P. 687–695.
9. Fagundes C., Ginès P. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis // Am. J. Kidney Dis. 2012. Vol. 59, № 6. P. 874–885.
10. Ginès P., Schrier R.W. Renal failure in cirrhosis // N. Engl. J. Med. 2009. Vol. 361, № 13. P. 1279–1290.
11. Henriksen J.H. et al. The sympathetic nervous system in liver disease // J. Hepatol. 1998. Vol. 29, № 2. P. 328–341.
12. Iwakiri Y., Groszmann R.J. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule // Hepatology. 2006. Vol. 43, № 2 Suppl 1. P. S121-31.
13. Martin P.Y., Ginès P., Schrier R.W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. // N. Engl. J. Med. 1998. Vol. 339, № 8. P. 533–541.
14. Martín-Llahí M. et al. Prognostic importance of the cause of renal failure in patients with cirrhosis // Gastroenterology. Elsevier Inc., 2011. Vol. 140, № 2. P. 488-496.e4.
15. Montoliu S. et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites // Clin. Gastroenterol. Hepatol. Elsevier Inc., 2010. Vol. 8, № 7. P. 616–622; quiz e80.
16. Ros J. et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat // Gastroenterology. 2002. Vol. 122, № 1. P. 85–93.
17. Tufoni M. et al. Albumin: Indications in chronic liver disease // United Eur. Gastroenterol. J. 2020. Vol. 8, № 5. P. 528–535.
18. Velez J.C.Q., Therapondos G., Juncos L.A. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis // Nat. Rev. Nephrol. 2020. Vol. 16, № 3. P. 137–155.
19. Wong F. et al. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation // Liver Transpl. 2015. Vol. 21, № 3. P. 300–307.
20. Zhang Z. et al. Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin // J. Crit. Care. 2015. Vol. 30, № 5. P. 969–974.
Number of Views: 89
Category of articles:
Clinical case
Bibliography link
Shakhanova A.T., Zhumadilova Z.K., Kaskabaeva A.Sh., Shakhanov T.E., Kapanova G.K., Botabaeva A.S., Kozhakhmetova D.K., Zhylkybaeva K.Sh., Muzdubaev D.K. Hepato-renal syndrome in cirrhosis of the liver. Clinical case // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (2), pp. 234-240. doi 10.34689/SH.2024.26.2.027Related publications:
THE COURSE OF SECONDARY SYPHILIS AT THE MODERN TIME
HEPATO-RENAL SYNDROME IN CIRRHOSIS OF THE LIVER. CLINICAL CASE.
A CLINICAL CASE OF NON-SMALL CELL THERAPY LUNG CANCER WITH PD-L1 EXPRESSION
RABIES - AN INFECTIOUS DISEASE WITH A FATAL OUTCOME (CLINICAL CASE)
ACTIVATION OF OPPOSITE PROCESSES – OSTEOPOROSIS AND OSTEOGENESIS IN ANKYLOSING SPONDYLITIS USING THE CLINICAL CASES